Evidence map›Paper›PMID 42539194›Full record

ArticlebioRxiv : the preprint server for biology2026

Prenatal cannabis exposure affects human fetal neurodevelopment: an integrated multi-omics study.

Guenther Kahlert, Xin Chen, Theo K Bammler, James W MacDonald, Lyndsey S Benson, Ian A Glass, Jennifer C Dempsey, Dilip Kumar Singh, Bhagwat Prasad, Jashvant D Unadkat

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guenther KahlertDepartment of Pharmaceutics, School of Pharmacy, University of Washington; Seattle, Washington 98195, USA.ORCID 0000-0002-3969-9547
Xin ChenDepartment of Pharmaceutics, School of Pharmacy, University of Washington; Seattle, Washington 98195, USA.
Theo K BammlerDepartment of Environmental and Occupational Health Sciences, University of Washington; Seattle, Washington 98195, USA.
James W MacDonaldDepartment of Environmental and Occupational Health Sciences, University of Washington; Seattle, Washington 98195, USA.
Lyndsey S BensonDepartment of Obstetrics and Gynecology, University of Washington School of Medicine; Seattle, Washington 98195, USA.
Ian A GlassBirth Defects Research Laboratory, Department of Pediatrics, University of Washington; Seattle, Washington 98195, USA.
Jennifer C DempseyBirth Defects Research Laboratory, Department of Pediatrics, University of Washington; Seattle, Washington 98195, USA.
Dilip Kumar SinghDivision of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio 45229, USA.
Bhagwat PrasadDivision of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center; Cincinnati, Ohio 45229, USA.
Jashvant D UnadkatDepartment of Pharmaceutics, School of Pharmacy, University of Washington; Seattle, Washington 98195, USA.

Funding

LABORATORY OF DEVELOPMENTAL BIOLOGYR24HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI Ian Amos Glass · 1995 to 2026
$16.9M
Understanding Fetal Exposure to Cannabinoids Through In Vitro and In Vivo StudiesP01DA032507 · NIDA · UNIVERSITY OF WASHINGTON · PI UNADKAT, JASHVANT D · 2013 to 2023
$12.4M
NICHD NIH HHS R24 HD000836NIDA NIH HHS P01 DA032507
6 · The paper itself

Abstract

Prenatal cannabis use is on the rise, and observational studies suggest that such use results in neurodevelopmental deficits in the offspring. Because observational studies can be confounded by unaccounted factors, we studied the neurodevelopmental consequences, at the molecular level, of prenatal cannabis use. We applied an integrated multi-omics approach, combining transcriptomics and global proteomics, to first trimester (T1) and second trimester (T2) human fetal brains from pregnancies with and without documented maternal cannabis exposure and no use of drugs of abuse. Prenatal cannabis exposure produced minimal molecular effects in female T1 fetal brains but induced pronounced system-level disruption in male T2 fetal brains. These disrupted pathways have molecular signatures linked to neurodevelopmental and neuropsychiatric disorders, including autism spectrum disorder, schizophrenia-related pathology, and disorders of cortical connectivity, raising significant concerns of prenatal cannabis use.

Identifiers

PMID42539194
PMCPMC13419773

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.